Delange F, Lecomte P
International Council for Control of Iodine Deficiency Disorders, Brussels, Belgium.
Drug Saf. 2000 Feb;22(2):89-95. doi: 10.2165/00002018-200022020-00001.
In 1990, iodine deficiency affected almost one-third of the world population and was the greatest single cause of preventable brain damage and mental retardation. Following a resolution adopted by the World Summit for Children in 1990. major programmes of iodine supplementation were implemented by the governments of the affected countries with the support of major donors. Iodisation of salt was recognised as the method of choice. Nine years later, by April 1999, 75% of the affected countries had legislation on salt iodisation and 68% of the affected populations had access to iodised salt. The prevalence of iodine deficiency disorders decreased drastically in most countries and the deficiency disappeared completely in some such as Peru. This result constitutes a public heath success unprecedented with a non-infectious disease. However, occasional adverse effects occurred. The principle effect is iodine-induced hyperthyroidism which occurs essentially in older people with autonomous nodular goitres, especially following iodine intake that is too rapid and of too massive an increment. The incidence of the disorder is usually low and reverts spontaneously to the background rate of hyperthyroidism or even below this rate after 1 to 10 years of iodine supplementation. The possible occurrence of iodine-induced thyroiditis in susceptible individuals has not been clearly demonstrated by large epidemiological surveys. Iodine supplementation is followed by an increased prevalence of occult papillary carcinoma of the thyroid discovered at autopsy but the prognosis of thyroid cancer is improved due to a shift towards differentiated forms of thyroid cancer that are diagnosed at earlier stages. Iodine-induced hyperthyroidism and other adverse effects can be almost entirely avoided by adequate and sustained quality control and monitoring of iodine supplementation which should also confirm adequate iodine intake. Available evidence clearly confirms that the benefits of correcting iodine deficiency far outweigh the risks of iodine supplementation.
1990年,碘缺乏影响了近三分之一的世界人口,是可预防脑损伤和智力迟钝的最大单一原因。1990年世界儿童问题首脑会议通过一项决议后,受影响国家的政府在主要捐助者的支持下实施了主要的补碘计划。食盐加碘被认为是首选方法。九年后,到1999年4月,75%的受影响国家制定了食盐加碘立法,68%的受影响人口能够获得加碘盐。大多数国家碘缺乏病的患病率大幅下降,在一些国家如秘鲁,碘缺乏完全消失。这一成果是一种非传染性疾病在公共卫生方面取得的前所未有的成功。然而,偶尔会出现不良反应。主要影响是碘致甲状腺功能亢进,基本上发生在患有自主性结节性甲状腺肿的老年人中,尤其是在碘摄入过快且增量过大之后。这种疾病的发病率通常较低,在补碘1至10年后会自发恢复到甲状腺功能亢进的背景发病率,甚至低于该发病率。大型流行病学调查尚未明确证实易感个体中可能发生碘致甲状腺炎。补碘后,尸检发现的甲状腺隐匿性乳头状癌患病率增加,但由于甲状腺癌向早期诊断的分化型转变,甲状腺癌的预后得到改善。通过对补碘进行充分和持续的质量控制及监测,几乎可以完全避免碘致甲状腺功能亢进和其他不良反应,这也应确认碘摄入充足。现有证据清楚地证实,纠正碘缺乏的益处远远超过补碘的风险。